As mentioned above, crosslinking between CSCs and two pathways- TNF-α/ NF-κB signaling and IL-6/STAT3- regulates the differentiation of many immune cells in TME, promoting immunosurveillance and cancer progression. The gene discussed is STAT3; the disease is cancer.